skip to main content
select
select
select
DateCaseTitleExpertiseCounsel
Sep 9, 2016 2016 FC 1013 Bayer Inc. v. Apotex Inc. and Cobalt Pharmaceuticals Company Following a six week trial, we obtained a judgment finding that Bayer’s patent covering YAZ and Yasmin birth control products was valid and i...

Patents

May 31, 2016 2016 FCA 161 Pfizer Canada Inc. v. Teva Canada Limited We overturned a section 8 damages award in excess of $100 million against our client, Pfizer, in respect of generic venlafaxine. 

Patents

May 31, 2016 2016 FC 593 Janssen Inc. v. Teva Canada Limited We obtained damages in excess of $18M for Teva’s infringement of a patent covering Janssen’s LEVAQUIN product.

Patents

May 27, 2016 2016 FC 581 Bayer Inc. et al. v Fresenius Kabi Canada Ltd. et al. We obtained an order preventing Fresenius from obtaining approval to market a generic version of Bayer’s AVELOX IV product until expiry of Bayer’s patent.  

Patents

Sep 24, 2015 2015 ONSC 5915 Lorama Group Inc. v. Lenz et al. We successfully opposed a summary judgment motion in a breach of confidence action.

Confidential Information/Trade Secrets

Sep 16, 2015 2015 FCA 192 Actavis Pharma Company v. Alcon Canada Inc. We successfully resisted Actavis’ appeal of the trial judge’s finding that the basic compound patent protecting VIGAMOX was valid.

Patents

Aug 31, 2015 Court File No. T-2247-14 Sanofi-Aventis Canada Inc. v. Eli Lilly Canada Inc. We successfully represented Eli Lilly in a patent proceeding relating to Eli Lilly’s diabetes medicine BASAGLAR. After filing a motion to dis...

Patents

May 28, 2015 Court File No. T-1337-13 Canadian Urban Transit Association v. Dovden Investments Ltd. By bringing an impeachment action on behalf of the Canadian Urban Transit Association, we successfully defended its members against threats of pate...

Patents

May 4, 2015 2015 FCA 116 Cobalt Pharmaceuticals Company v. Bayer Inc. We successfully represented Bayer in appeals from a decision of the Federal Court regarding patents covering oral contraceptives containing drospir...

Patents

Oct 28, 2014 2014 FCA 242 Janssen Inc. v. Abbvie Corporation We successfully represented Janssen on this appeal from a refusal to grant an amendment to Janssen’s pleading.  The Court of Appeal agre...

Patents

Oct 16, 2014 2014 FC 989 Denturist Group of Ontario v. Denturist Association of Canada We successfully represented the Denturist Group of Ontario in trademark and copyright litigation.

Copyright

Oct 1, 2014 Court File No. A-45-14 Takeda v. Apotex We represented Takeda on appeals from a section 8 damages action relating to pantoprozole (PANTOLOC®). The appeals were resolved prior to a hea...

Patents

May 14, 2014 2014 FC 462 Alcon Canada Inc. v. Cobalt Pharmaceuticals Company We successfully defended the validity of Bayer’s key patent covering the anti-infective moxifloxacin (AVELOX® and VIGAMOX ®) and obta...

Patents

May 7, 2014 2014 FC 436 Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Apotex Inc. and the Minister of Health The validity of Bayer’s key patent covering the oral contraceptives YASMIN® and YAZ® was upheld by the Federal Court.

Patents

Apr 3, 2014 2014 FC 248 Teva Canada Limited v. Pfizer Canada Inc. We represented Pfizer in defending a damages case pursuant to section 8 of the Patented Medicines (Notice of Compliance) Regulations.

Patents

Feb 14, 2014 2014 FC 149 Alcon Canada Inc. v. Cobalt Pharmaceuticals Company - 2014 FC 149 This case involves an application for an order in the nature of prohibition to restrain the Minister of Health from issuing a Notice of Compliance ...

Patents

Dec 11, 2013 2013 FC 1237 Apotex Inc. v. Takeda Canada Inc. We represented Takeda in defending a damages case pursuant to section 8 of the Patented Medicines (Notice of Compliance) Regulations.

Patents

Oct 22, 2013 2013 FC 1061 Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Cobalt Pharmaceuticals Company and the Minister of Health We represented Bayer and obtained a prohibition order against Cobalt’s generic version of Bayer’s YAZ® (drospirenone / ethinyl estr...

Patents

Oct 8, 2013 2013 FCA 240 Bodum USA, Inc. v. Meyer Housewares Canada Inc. Mark Davis successfully defended an appeal from the trial judge’s determination that the trademark being asserted against his client was inva...

Trademarks

Aug 12, 2013 2013 FC 750 Varco Canada Limited v. Pason Systems Corp. Peter Wilcox acted for National Oilwell Varco as lead counsel in a patent infringement and validity trial related to automatic drilling equipment f...

Patents

Apr 17, 2013 2013 FCA 107 Beyond the Rack Enterprises Inc. v. Michael Kors Mark Davis successfully acted for Michael Kors on this appeal contesting the sufficiency of pleadings.

Trademarks

Dec 10, 2012 2012 FC 1450 Bodum USA, Inc. v. Meyer Housewares Canada Inc. Mark Davis successfully invalidated the trademark “FRENCH PRESS” which was being asserted against his client, Meyer Housewares Canada.

Trademarks

Apr 11, 2012 2012 FC 410 Alcon Canada Inc. v. Apotex Inc. We represented Alcon in a proceeding under the Patented Medicines (Notice of Compliance) Regulations relating to PATANOL.

Patents

Mar 11, 2011 2011 FC 239 GlaxoSmithKline Inc. v. Pharmascience Inc. Peter Wilcox successfully acted for GlaxoSmithKline in a proceeding in which attacks on the validity of the patent covering GSK’s diabetes me...

Patents

Jul 12, 2010 2010 FC 741 Nicholas v. Environmental Systems (International) Limited Peter Wilcox acted for Environmental Systems (International) and Reif Estate Wineries at trial in the successful defence of a $27 million copyright...

Copyright

May 12, 2010 2010 FC 42 Janssen-Ortho Inc. v. Canada (Health) Lindsay Neidrauer represented Janssen-Ortho and Alza Corporation in a proceeding under the Patented Medicines (Notice of Compliance) Regulations re...

Patents

Apr 14, 2010 2010 FC 409 Pfizer Canada Inc. v. Novopharm Limited Peter Wilcox acted for Pfizer in various proceedings relating to pregabalin (LYRICA®).

Patents

Jun 26, 2009 2009 FC 671 Pfizer Canada Inc. v. Apotex Inc. Peter Wilcox acted for Pfizer in a proceeding related to amlodipine (NORVASC®), including successfully resisting a motion to dismiss.

Patents

Jun 22, 2009 2009 FCA 212 Janssen-Ortho Inc. v. Apotex Inc. Neil Belmore and Lindsay Neidrauer were successful in preventing Apotex from marketing a generic version of LEVAQUIN®.  This appeal involv...

Patents

Nov 6, 2008 2008 SCC 61 Apotex Inc. v. Sanofi-Synthelabo Canada Inc. Peter Wilcox acted for BIOTECanada, an intervener in the Supreme Court of Canada.  BIOTECanada supported the successful respondent Sanofi in t...

Patents

Oct 24, 2008 2008 FC 1195 Lotech Medical Systems Limited v. Kinetic Concepts Inc. Peter Wilcox acted Kinetic Concepts in the Federal Court in a patent infringement and validity action related to therapeutic mattresses.

Patents

Jun 17, 2008 2008 FC 744 Janssen-Ortho Inc. v. Apotex Inc. Neil Belmore and Lindsay Neidrauer successfully obtained a prohibition order preventing Apotex from launching a generic version of LEVAQUIN®.

Patents

Apr 8, 2008 2008 FC 454 Nycomed Canada Inc. v. Novopharm Ltd. This is a motion by the Respondent, Novopharm Limited (Novopharm), pursuant to section 6(5)(b) of the Patented Medicines Notice of Compliance Regul...

Patents

Mar 20, 2008 2008 FCA 108 Pfizer Canada Inc. v. Canada (Health) - 2008 FCA 108 Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against variou...

Patents

Mar 10, 2008 2008 FC 330 Nycomed GmbH v. Canada (Minister of Health) Neil Belmore and Lindsay Neidrauer successfully defended against a motion to dismiss a proceeding for a prohibition application in respect of PANTO...

Patents

Mar 6, 2008 2008 FC 308 Solvay Pharma Inc. v. Apotex Inc. Neil Belmore and Lindsay Neidrauer represented Solvay Pharma and Altana Pharma in an application for a prohibition order to prevent Apotex from mar...

Patents

Oct 5, 2007 2007 FC 898 Pfizer Canada Inc. v. Canada (Health) - 2007 FC 898 Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against variou...

Patents

Aug 23, 2007 2007 FCA 269 Janssen-Ortho Inc. v. Novopharm Ltd. Neil Belmore and Lindsay Neidrauer successfully represented Janssen-Ortho on this appeal from a motion to reconsider.

Patents

Jun 22, 2007 2007 FCA 243 Apotex Inc. v. Bayer AG Neil Belmore and Lindsay Neidrauer successfully represented Bayer on this appeal relating to CIPRO®.

Patents

Jun 18, 2007 2007 FC 649 Pfizer Canada Inc. v. Canada (Health) - 2007 FC 649 Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against variou...

Patents

Jun 7, 2007 2007 FCA 217 Janssen-Ortho Inc. v. Novopharm Ltd. Neil Belmore and Lindsay Neidrauer successfully represented Janssen-Ortho on this appeal from the trial decision finding that Novopharm’s cha...

Patents

Dec 7, 2006 2006 FC 1471 Pfizer Canada Inc. v. Canada (Minister of Health) Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (Lipitor) against various gen...

Patents

Dec 7, 2006 2006 FC 1471 Pfizer Canada Inc. v. Canada (Minister of Health) - 2006 FC 1471 Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against various generic drug companies.

Patents

Oct 3, 2005 2005 FC 1299 Pfizer Canada Inc. v. Novopharm Ltd. Lindsay Neidrauer successfully acted for Pfizer in respect of its ZITHROMAX® antibiotic and obtained a prohibition order against Novopharm&rsqu...

Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy